Medicine and Dentistry
Proteomics
100%
Leukemia
100%
Leukemia Cell
100%
In Vitro
100%
Leukemia Cell Line
100%
Cancer Peptide
50%
Polypeptide Antibiotic Agent
50%
Programmed Cell Death
50%
Doctor of Philosophy
50%
Combination Therapy
50%
Doxorubicin
50%
Anticarcinogen
50%
Pharmacokinetics
50%
Mass Spectrum
50%
Oncology
50%
Hematological Cancer
50%
Antileukemic Agent
50%
Diagnosis
50%
Immunity
50%
DNA Repair
50%
Clinical Trial
50%
Biochemistry, Genetics and Molecular Biology
Proteomics
100%
In Vitro Study
100%
Anticancer
100%
In Vivo Study
50%
Pharmacokinetics
50%
Programmed Cell Death
50%
Mass Spectrometry
50%
Clinical Trial
50%
Antimicrobial Peptides
50%
DNA Repair
50%
Animal Model
50%
Cancer Peptide
50%
Immunity
50%
Doxorubicin
50%
Keyphrases
Antileukemic Activity
100%
Middlesex
100%
Leukemia
66%
Novel Peptide
66%
Mechanism of Action
66%
Natural Sciences
66%
Clinical Setting
66%
Leukemia Cells
66%
In Vitro Study
66%
Proteomic Profiling
66%
Gene Expression Profiling
66%
